SE0000872095
SE0000872095
Swedish Orphan Biovitrum AB
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 149.09B EUR | 160.45B EUR | 135.64B EUR |
Enterprise Value | 165.29B EUR | 176.95B EUR | 153.76B EUR |
Valuation Multiples | |||
Trailing P/E | 111.56x | 32.66x | 28.92x |
Forward P/E | 27.55x | -- | -- |
Price to Sales | 4.87x | 5.53x | 4.91x |
Price to Book | 3.52x | 3.8x | 3.36x |
EV/Revenue | 5.4x | 6.1x | 5.56x |
EV/EBITDA | 13.32x | 15.12x | 15.03x |
Price to FCF (P/FCF) | 43.65x | 25.01x | 19.03x |
EV/FCF | 48.39x | 27.58x | 21.57x |
FCF Yield | 2.29% | 4% | 5.26% |